Polaryx Therapeutics, Inc
Fundamentals
Oldest to newest| Line | Dec 2024 | Dec 2025 |
|---|---|---|
| Operating income | −$4.4M | −$7.8M |
| Net income | −$30.4M | −$9.0M |
| Operating cash flow | −$2.6M | −$3.9M |
| Cash | $4.6M | $5.1M |
| Shares outstanding | 41.2M | 47.3M |
| Line | Dec 2024 | Dec 2025 |
|---|---|---|
| Operating income | −$4.4M | −$7.8M |
| Net income | −$30.4M | −$9.0M |
| Operating cash flow | −$2.6M | −$3.9M |
| Cash | $4.6M | $5.1M |
| Shares outstanding | 41.2M | 47.3M |